Bempedoic Acid and the Prevention of Cardiovascular Disease

N Engl J Med. 2023 Apr 13;388(15):1427-1430. doi: 10.1056/NEJMe2300793. Epub 2023 Mar 4.

Author

John F Keaney Jr¹

Affiliation

¹ From the Division of Cardiovascular Medicine and the Heart and Vascular Center, Brigham and Women's Hospital, and Harvard Medical School - both in Boston.

PMID: 36876758
DOI: 10.1056/NEJMe2300793

No abstract available

Publication types

Editorial

MeSH terms

Cardiovascular Diseases* / prevention & control
Dicarboxylic Acids / therapeutic use
Fatty Acids / therapeutic use
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
Hypolipidemic Agents* / therapeutic use

Substances

8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid
Dicarboxylic Acids
Fatty Acids
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents